Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1357

1.

Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop.

Cook JA, Julious SA, Sones W, Hampson LV, Hewitt C, Berlin JA, Ashby D, Emsley R, Fergusson DA, Walters SJ, Wilson EC, MacLennan G, Stallard N, Rothwell JC, Bland M, Brown L, Ramsay CR, Cook A, Armstrong D, Altman D, Vale LD.

Health Technol Assess. 2019 Oct;23(60):1-88. doi: 10.3310/hta23600.

2.

Blurred Molecular Epidemiological Lines Between the Two Dominant Methicillin-Resistant Staphylococcus aureus Clones.

Dupper AC, Sullivan MJ, Chacko KI, Mishkin A, Ciferri B, Kumaresh A, Berbel Caban A, Oussenko I, Beckford C, Zeitouni NE, Sebra R, Hamula C, Smith M, Kasarskis A, Patel G, McBride RB, van Bakel H, Altman DR.

Open Forum Infect Dis. 2019 Jun 27;6(9):ofz302. doi: 10.1093/ofid/ofz302. eCollection 2019 Sep.

3.

Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidance.

Sones W, Julious SA, Rothwell JC, Ramsay CR, Hampson LV, Emsley R, Walters SJ, Hewitt C, Bland M, Fergusson DA, Berlin JA, Altman D, Vale LD, Cook JA.

Trials. 2019 Oct 24;20(1):602. doi: 10.1186/s13063-019-3809-2.

4.

Reporting of randomized factorial trials was frequently inadequate.

Kahan BC, Tsui M, Jairath V, Scott AM, Altman DG, Beller E, Elbourne D.

J Clin Epidemiol. 2019 Oct 1;117:52-59. doi: 10.1016/j.jclinepi.2019.09.018. [Epub ahead of print] Review.

PMID:
31585174
5.

A complete genome screening program of clinical methicillin-resistant Staphylococcus aureus isolates identifies the origin and progression of a neonatal intensive care unit outbreak.

Sullivan MJ, Altman DR, Chacko KI, Ciferri B, Webster E, Pak TR, Deikus G, Lewis-Sandari M, Khan Z, Beckford C, Rendo A, Samaroo F, Sebra R, Karam-Howlin R, Dingle T, Hamula C, Bashir A, Schadt E, Patel G, Wallach F, Kasarskis A, Gibbs K, van Bakel H.

J Clin Microbiol. 2019 Oct 2. pii: JCM.01261-19. doi: 10.1128/JCM.01261-19. [Epub ahead of print]

6.

Relationships of Trait Anxiety and Loss of Control Eating with Serum Leptin Concentrations among Youth.

Byrne ME, Tanofsky-Kraff M, Jaramillo M, Shank LM, LeMay-Russell S, Rubin SG, Ramirez S, Altman DR, Schvey NA, Brady SM, Shomaker LB, Courville AB, Yang SB, Kozlosky M, Broadney MM, Yanovski SZ, Yanovski JA.

Nutrients. 2019 Sep 12;11(9). pii: E2198. doi: 10.3390/nu11092198.

7.

Evaluation of bacterial presence on lead X-ray aprons utilised in the operating room via IBIS and standard culture methods.

Jain S, Rajfer RA, Melton-Kreft R, Nistico L, Miller MC, Stoodley P, Altman DT, Altman GT.

J Infect Prev. 2019 Jul;20(4):191-196. doi: 10.1177/1757177419833163. Epub 2019 Apr 15.

PMID:
31428200
8.

Childhood obesity intervention studies: A narrative review and guide for investigators, authors, editors, reviewers, journalists, and readers to guard against exaggerated effectiveness claims.

Brown AW, Altman DG, Baranowski T, Bland JM, Dawson JA, Dhurandhar NV, Dowla S, Fontaine KR, Gelman A, Heymsfield SB, Jayawardene W, Keith SW, Kyle TK, Loken E, Oakes JM, Stevens J, Thomas DM, Allison DB.

Obes Rev. 2019 Nov;20(11):1523-1541. doi: 10.1111/obr.12923. Epub 2019 Aug 19. Review.

PMID:
31426126
9.

CONSORT 2010 statement: extension to randomised crossover trials.

Dwan K, Li T, Altman DG, Elbourne D.

BMJ. 2019 Jul 31;366:l4378. doi: 10.1136/bmj.l4378. No abstract available.

10.

The association between alexithymia and eating behavior in children and adolescents.

Shank LM, Tanofsky-Kraff M, Kelly NR, Jaramillo M, Rubin SG, Altman DR, Byrne ME, LeMay-Russell S, Schvey NA, Broadney MM, Brady SM, Yang SB, Courville AB, Ramirez S, Crist AC, Yanovski SZ, Yanovski JA.

Appetite. 2019 Nov 1;142:104381. doi: 10.1016/j.appet.2019.104381. Epub 2019 Jul 22.

PMID:
31344421
11.

Associations of Weekday and Weekend Sleep with Children's Reported Eating in the Absence of Hunger.

LeMay-Russell S, Tanofsky-Kraff M, Schvey NA, Kelly NR, Shank LM, Mi SJ, Jaramillo M, Ramirez S, Altman DR, Rubin SG, Byrne ME, Burke NL, Davis EK, Broadney MM, Brady SM, Yanovski SZ, Yanovski JA.

Nutrients. 2019 Jul 20;11(7). pii: E1658. doi: 10.3390/nu11071658.

12.

Methods for the Watch the Spot Trial: A Pragmatic Trial of More vs. Less Intensive Strategies for Active Surveillance of Small Pulmonary Nodules.

Gould MK, Smith-Bindman R, Kelly K, Altman DE, Barjaktarevic I, Creekmur B, de Bie E, Dyer DS, Mortani Barbosa EJ Jr, Mularski RA, Qi L, Vaszar LT, Yu S, Miglioretti DL; Watch the Spot Trial Investigators .

Ann Am Thorac Soc. 2019 Jul 17. doi: 10.1513/AnnalsATS.201903-268SD. [Epub ahead of print]

PMID:
31314549
13.

Completeness of reporting of randomised controlled trials including people with transient ischaemic attack or stroke: A systematic review.

Wilson B, Burnett P, Moher D, Altman DG, Al-Shahi Salman R.

Eur Stroke J. 2018 Dec;3(4):337-346. doi: 10.1177/2396987318782783. Epub 2018 Jun 20. Review.

14.

Can we be certain that storage duration of transfused red blood cells does not affect patient outcomes?

Trivella M, Stanworth SJ, Brunskill S, Dutton P, Altman DG.

BMJ. 2019 Jun 11;365:l2320. doi: 10.1136/bmj.l2320. No abstract available.

PMID:
31186250
15.

Adherence to reporting guidelines increases the number of citations: the argument for including a methodologist in the editorial process and peer-review.

Vilaró M, Cortés J, Selva-O'Callaghan A, Urrutia A, Ribera JM, Cardellach F, Basagaña X, Elmore M, Vilardell M, Altman D, González JA, Cobo E.

BMC Med Res Methodol. 2019 May 31;19(1):112. doi: 10.1186/s12874-019-0746-4.

16.

Clinical Outcomes After Spine Surgery for Traumatic Injury in the Octogenarian Population.

Mao G, Gigliotti MJ, Tomycz N, Altman DT, Philp FH.

World Neurosurg. 2019 Sep;129:e97-e103. doi: 10.1016/j.wneu.2019.05.048. Epub 2019 May 14.

PMID:
31100527
17.

Scoping review on interventions to improve adherence to reporting guidelines in health research.

Blanco D, Altman D, Moher D, Boutron I, Kirkham JJ, Cobo E.

BMJ Open. 2019 May 9;9(5):e026589. doi: 10.1136/bmjopen-2018-026589.

18.

Uniformity in measuring adherence to reporting guidelines: the example of TRIPOD for assessing completeness of reporting of prediction model studies.

Heus P, Damen JAAG, Pajouheshnia R, Scholten RJPM, Reitsma JB, Collins GS, Altman DG, Moons KGM, Hooft L.

BMJ Open. 2019 Apr 24;9(4):e025611. doi: 10.1136/bmjopen-2018-025611.

19.

Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement.

Juszczak E, Altman DG, Hopewell S, Schulz K.

JAMA. 2019 Apr 23;321(16):1610-1620. doi: 10.1001/jama.2019.3087.

PMID:
31012939
20.

Five-year costs from a randomised comparison of bilateral and single internal thoracic artery grafts.

Little M, Gray A, Altman D, Benedetto U, Flather M, Gerry S, Lees B, Murphy J, Campbell H, Taggart D.

Heart. 2019 Aug;105(16):1237-1243. doi: 10.1136/heartjnl-2018-313932. Epub 2019 Apr 4.

21.

Delivery outcome after trial of labor in nulliparous women 40 years or older-A nationwide population-based study.

Ankarcrona V, Altman D, Wikström AK, Jacobsson B, Brismar Wendel S.

Acta Obstet Gynecol Scand. 2019 Sep;98(9):1195-1203. doi: 10.1111/aogs.13614. Epub 2019 Apr 19.

PMID:
30901074
22.

Urodynamics as a Prognosticator of Mirabegron Treatment Outcomes.

Kopp Kallner H, Elmér C, Altman D.

Gynecol Obstet Invest. 2019;84(5):472-476. doi: 10.1159/000496606. Epub 2019 Mar 21.

PMID:
30897579
23.

COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology.

Dekkers OM, Vandenbroucke JP, Cevallos M, Renehan AG, Altman DG, Egger M.

PLoS Med. 2019 Feb 21;16(2):e1002742. doi: 10.1371/journal.pmed.1002742. eCollection 2019 Feb.

24.

En coup de sabre.

Graham PM, Gupta N, Altman DA.

Cutis. 2019 Jan;103(1):34-36.

PMID:
30758333
25.

Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement.

Kirkham JJ, Gorst S, Altman DG, Blazeby JM, Clarke M, Tunis S, Williamson PR; COS-STAP Group.

Trials. 2019 Feb 11;20(1):116. doi: 10.1186/s13063-019-3230-x.

26.

A guide to systematic review and meta-analysis of prognostic factor studies.

Riley RD, Moons KGM, Snell KIE, Ensor J, Hooft L, Altman DG, Hayden J, Collins GS, Debray TPA.

BMJ. 2019 Jan 30;364:k4597. doi: 10.1136/bmj.k4597. No abstract available.

PMID:
30700442
27.

Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years.

Taggart DP, Benedetto U, Gerry S, Altman DG, Gray AM, Lees B, Gaudino M, Zamvar V, Bochenek A, Buxton B, Choong C, Clark S, Deja M, Desai J, Hasan R, Jasinski M, O'Keefe P, Moraes F, Pepper J, Seevanayagam S, Sudarshan C, Trivedi U, Wos S, Puskas J, Flather M; Arterial Revascularization Trial Investigators.

N Engl J Med. 2019 Jan 31;380(5):437-446. doi: 10.1056/NEJMoa1808783.

PMID:
30699314
28.

Sequential evolution of virulence and resistance during clonal spread of community-acquired methicillin-resistant Staphylococcus aureus.

Copin R, Sause WE, Fulmer Y, Balasubramanian D, Dyzenhaus S, Ahmed JM, Kumar K, Lees J, Stachel A, Fisher JC, Drlica K, Phillips M, Weiser JN, Planet PJ, Uhlemann AC, Altman DR, Sebra R, van Bakel H, Lighter J, Torres VJ, Shopsin B.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1745-1754. doi: 10.1073/pnas.1814265116. Epub 2019 Jan 11. Erratum in: Proc Natl Acad Sci U S A. 2019 Feb 25;:.

29.

CONSORT 2010 statement: extension checklist for reporting within person randomised trials.

Pandis N, Chung B, Scherer RW, Elbourne D, Altman DG.

Br J Dermatol. 2019 Mar;180(3):534-552. doi: 10.1111/bjd.17239. Epub 2019 Jan 4.

PMID:
30609010
30.

DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.

Cook JA, Julious SA, Sones W, Hampson LV, Hewitt C, Berlin JA, Ashby D, Emsley R, Fergusson DA, Walters SJ, Wilson ECF, MacLennan G, Stallard N, Rothwell JC, Bland M, Brown L, Ramsay CR, Cook A, Armstrong D, Altman D, Vale LD.

BMJ. 2018 Nov 5;363:k3750. doi: 10.1136/bmj.k3750. No abstract available.

31.

Statistical methodology for constructing gestational age-related charts using cross-sectional and longitudinal data: The INTERGROWTH-21st project as a case study.

Ohuma EO, Altman DG; International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st Project).

Stat Med. 2019 Aug 30;38(19):3507-3526. doi: 10.1002/sim.8018. Epub 2018 Nov 28.

32.

Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design.

Dimairo M, Coates E, Pallmann P, Todd S, Julious SA, Jaki T, Wason J, Mander AP, Weir CJ, Koenig F, Walton MK, Biggs K, Nicholl J, Hamasaki T, Proschan MA, Scott JA, Ando Y, Hind D, Altman DG.

BMC Med. 2018 Nov 16;16(1):210. doi: 10.1186/s12916-018-1196-2.

33.

A cross-sectional bibliometric study showed suboptimal journal endorsement rates of STROBE and its extensions.

Sharp MK, Tokalić R, Gómez G, Wager E, Altman DG, Hren D.

J Clin Epidemiol. 2019 Mar;107:42-50. doi: 10.1016/j.jclinepi.2018.11.006. Epub 2018 Nov 10.

34.

DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.

Cook JA, Julious SA, Sones W, Hampson LV, Hewitt C, Berlin JA, Ashby D, Emsley R, Fergusson DA, Walters SJ, Wilson ECF, Maclennan G, Stallard N, Rothwell JC, Bland M, Brown L, Ramsay CR, Cook A, Armstrong D, Altman D, Vale LD.

Trials. 2018 Nov 5;19(1):606. doi: 10.1186/s13063-018-2884-0.

35.

Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review.

Kempf E, de Beyer JA, Cook J, Holmes J, Mohammed S, Nguyên TL, Simera I, Trivella M, Altman DG, Hopewell S, Moons KGM, Porcher R, Reitsma JB, Sauerbrei W, Collins GS.

Br J Cancer. 2018 Nov;119(10):1288-1296. doi: 10.1038/s41416-018-0305-5. Epub 2018 Oct 24.

36.

Design and other methodological considerations for the construction of human fetal and neonatal size and growth charts.

Ohuma EO, Altman DG; International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st Project).

Stat Med. 2019 Aug 30;38(19):3527-3539. doi: 10.1002/sim.8000. Epub 2018 Oct 23.

37.

Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidance.

Sones W, Julious SA, Rothwell JC, Ramsay CR, Hampson LV, Emsley R, Walters SJ, Hewitt C, Bland M, Fergusson DA, Berlin JA, Altman D, Vale LD, Cook JA.

Trials. 2018 Oct 10;19(1):542. doi: 10.1186/s13063-018-2887-x. Erratum in: Trials. 2019 Oct 24;20(1):602.

38.

A High-fidelity Tactile Hand Simulator as a Training Tool to Develop Competency in Percutaneous Pinning in Residents.

Wu YY, Rajaraman M, Guth J, Salopek T, Altman D, Sangimino M, Shimada K.

J Am Acad Orthop Surg Glob Res Rev. 2018 Jul 13;2(7):e028. doi: 10.5435/JAAOSGlobal-D-18-00028. eCollection 2018 Jul.

39.

Outcome reporting bias in trials: a methodological approach for assessment and adjustment in systematic reviews.

Kirkham JJ, Altman DG, Chan AW, Gamble C, Dwan KM, Williamson PR.

BMJ. 2018 Sep 28;362:k3802. doi: 10.1136/bmj.k3802. No abstract available.

40.

A role for myosin VI in retinal pigment epithelium phagocytosis.

Hewage N, Altman D.

Biochem Biophys Res Commun. 2018 Oct 12;504(4):759-764. doi: 10.1016/j.bbrc.2018.09.006. Epub 2018 Sep 11.

PMID:
30217454
41.

Genome Plasticity of agr-Defective Staphylococcus aureus during Clinical Infection.

Altman DR, Sullivan MJ, Chacko KI, Balasubramanian D, Pak TR, Sause WE, Kumar K, Sebra R, Deikus G, Attie O, Rose H, Lewis M, Fulmer Y, Bashir A, Kasarskis A, Schadt EE, Richardson AR, Torres VJ, Shopsin B, van Bakel H.

Infect Immun. 2018 Sep 21;86(10). pii: e00331-18. doi: 10.1128/IAI.00331-18. Print 2018 Oct.

42.

Management of Sacroiliac Joint Pain.

Schmidt GL, Bhandutia AK, Altman DT.

J Am Acad Orthop Surg. 2018 Sep 1;26(17):610-616. doi: 10.5435/JAAOS-D-15-00063. Review.

PMID:
30059395
43.

The STROBE Extensions: Considerations for Development.

Sharp MK, Hren D, Altman DG.

Epidemiology. 2018 Nov;29(6):e53-e56. doi: 10.1097/EDE.0000000000000899. No abstract available.

PMID:
30052544
44.

Poor reporting of multivariable prediction model studies: towards a targeted implementation strategy of the TRIPOD statement.

Heus P, Damen JAAG, Pajouheshnia R, Scholten RJPM, Reitsma JB, Collins GS, Altman DG, Moons KGM, Hooft L.

BMC Med. 2018 Jul 19;16(1):120. doi: 10.1186/s12916-018-1099-2.

45.

Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT.

Selby PJ, Banks RE, Gregory W, Hewison J, Rosenberg W, Altman DG, Deeks JJ, McCabe C, Parkes J, Sturgeon C, Thompson D, Twiddy M, Bestall J, Bedlington J, Hale T, Dinnes J, Jones M, Lewington A, Messenger MP, Napp V, Sitch A, Tanwar S, Vasudev NS, Baxter P, Bell S, Cairns DA, Calder N, Corrigan N, Del Galdo F, Heudtlass P, Hornigold N, Hulme C, Hutchinson M, Lippiatt C, Livingstone T, Longo R, Potton M, Roberts S, Sim S, Trainor S, Welberry Smith M, Neuberger J, Thorburn D, Richardson P, Christie J, Sheerin N, McKane W, Gibbs P, Edwards A, Soomro N, Adeyoju A, Stewart GD, Hrouda D.

Southampton (UK): NIHR Journals Library; 2018 Jun.

46.

Corrigendum to "Community-Acquired Cavitary Pseudomonas Pneumonia Linked to Use of a Home Humidifier".

Woods EC, Cohen GM, Bressman E, Lin D, Zeitouni NE, Beckford C, Hamula C, van Bakel H, Sullivan M, Altman DR, Caplivski D.

Case Rep Infect Dis. 2018 Jun 5;2018:6548482. doi: 10.1155/2018/6548482. eCollection 2018.

47.

Sample size for binary logistic prediction models: Beyond events per variable criteria.

van Smeden M, Moons KG, de Groot JA, Collins GS, Altman DG, Eijkemans MJ, Reitsma JB.

Stat Methods Med Res. 2019 Aug;28(8):2455-2474. doi: 10.1177/0962280218784726. Epub 2018 Jul 3.

48.

Some methodological issues in the design and analysis of cluster randomised trials.

Mansournia MA, Altman DG.

Br J Sports Med. 2019 May;53(9):573-575. doi: 10.1136/bjsports-2018-099628. Epub 2018 Jun 14. No abstract available.

PMID:
29903855
49.

'Allocation concealment': the evolution and adoption of a methodological term.

Schulz KF, Chalmers I, Altman DG, Grimes DA, Moher D, Hayes RJ.

J R Soc Med. 2018 Jun;111(6):216-224. doi: 10.1177/0141076818776604. Review. No abstract available.

50.

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration.

Sauerbrei W, Taube SE, McShane LM, Cavenagh MM, Altman DG.

J Natl Cancer Inst. 2018 Aug 1;110(8):803-811. doi: 10.1093/jnci/djy088. Review.

Supplemental Content

Loading ...
Support Center